Thibault Kervarrec Selected Research

Thymoma (Thymic Carcinoma)

11/2020

Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thibault Kervarrec Research Topics

Disease

18	Neoplasms (Cancer) 10/2023 - 01/2018
15	Merkel Cell Carcinoma 12/2023 - 08/2018
2	Melanoma (Melanoma, Malignant) 10/2023 - 06/2019
2	Carcinogenesis 01/2020 - 05/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Poroma 05/2023
1	Poliomyelitis (Polio) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Fibrosis (Cirrhosis) 10/2021
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 01/2021
1	Thymoma (Thymic Carcinoma) 11/2020
1	Skin Neoplasms (Skin Cancer) 10/2020
1	Malaria 04/2020
1	Halo Nevus 06/2019
1	Neuroendocrine Carcinoma 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Dermatitis 12/2016
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 12/2016
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 07/2015

Drug/Important Bio-Agent (IBA)

6	Tumor Viral Antigens (Large T Antigen)IBA 04/2023 - 05/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 05/2018
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 02/2022 - 01/2022
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 10/2019
2	pembrolizumabIBA 12/2020 - 06/2019
2	AntigensIBA 10/2019 - 08/2018
2	Keratin-20 (Cytokeratin 20)IBA 01/2019 - 05/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2023
1	Aurora Kinase AIBA 04/2023
1	VaccinesIBA 01/2023
1	Monoclonal AntibodiesIBA 02/2022
1	Cytotoxins (Cytolysins)IBA 02/2022
1	Glycogen Synthase Kinase 3IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 01/2022
1	codrituzumabIBA 01/2022
1	GlypicansIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 12/2020
1	cyclopropapyrroloindoleIBA 12/2020
1	talimogene laherparepvecIBA 11/2020
1	InterferonsIBA 11/2020
1	ArtesunateIBA 04/2020
1	Keratin-8 (Keratin 8)IBA 11/2019
1	EpitopesIBA 10/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 08/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2018
1	Thyroid Nuclear Factor 1IBA 05/2018
1	Keratins (Keratin)IBA 01/2018
1	Leflunomide (Arava)FDA LinkGeneric 12/2016
1	Ustekinumab (CNTO 1275)FDA Link 12/2016
1	Thalidomide (Thalomid)FDA Link 07/2015
1	Methotrexate (Mexate)FDA LinkGeneric 07/2015
1	Acitretin FDA Link 07/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015

Therapy/Procedure

5	Therapeutics 01/2023 - 04/2020
3	Immunotherapy 11/2020 - 10/2019
1	Palliative Care (Palliative Therapy) 10/2023
1	Radiotherapy 10/2023
1	Subcutaneous Injections 11/2020